Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Saleem, Imran Y ^a   Smyth, Hugh D C ^b  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APAFLURANE; EXCIPIENT; SOLVENT; SURFACTANT; AEROSOL; ALCOHOL; FLUORESCEIN; FLUORINATED HYDROCARBON; NORFLURANE; POLOXAMER;

AEROSOL; ARTICLE; CONCENTRATION (PARAMETERS); LASER DIFFRACTION; METERED DOSE INHALER; PARTICLE SIZE; CHEMISTRY; MEDICINAL CHEMISTRY;

AEROSOLS; CHEMISTRY, PHARMACEUTICAL; ETHANOL; FLUORESCEIN; HYDROCARBONS, FLUORINATED; METERED DOSE INHALERS; PARTICLE SIZE; POLOXAMER; SOLVENTS; SURFACE-ACTIVE AGENTS;

EID: 84881537639     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/574310     Document Type: Article

References (31)

1. Courrier H. M., Butz N., Vandamme T. F., Pulmonary drug delivery systems: recent developments and prospects. Critical Reviews in Therapeutic Drug Carrier Systems 2002 19 4-5 425 498 2-s2.0-0036940766 10.1615/ CritRevTherDrugCarrierSyst.v19.i45.40 (Pubitemid 36314479)
2. Dunbar C. A., Atomization mechanisms of the pressurized metered dose inhaler. Particulate Science and Technology 1997 15 3-4 253 271 2-s2.0-0031389982 (Pubitemid 28449122)
3. McDonald K. J., Martin G. P., Transition to CFC-free metered dose inhalers-into the new millennium. International Journal of Pharmaceutics 2000 201 1 89 107 2-s2.0-0034658554 10.1016/S0378-5173(00)00401-4 (Pubitemid 30364973)
4. Noakes T. J., CFC's their replacement and the ozone layer. Journal of Aerosol Medicine 1995 8 supplement 1 S3 S7
5. Vervaet C., Byron P. R., Drug-surfactant-propellant interactions in HFA-formulations. International Journal of Pharmaceutics 1999 186 1 13 30 2-s2.0-0032790248 10.1016/S0378-5173(99)00134-9 (Pubitemid 29397519)
6. Alexander D. J., Safety of propellants. Journal of Aerosol Medicine 1995 8 1 S29 S34 2-s2.0-0029162644
7. Blondino F. E., Byron P. R., Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants. Drug Development and Industrial Pharmacy 1998 24 10 935 945 2-s2.0-0031679782 (Pubitemid 28470970)
8. Smyth H. D. C., The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Advanced Drug Delivery Reviews 2003 55 7 807 828 2-s2.0-0038433196 10.1016/S0169-409X(03)00079-6 (Pubitemid 36776795)
9. Leach C. L., Davidson P. J., Boudreau R. J., Improved airway targeting with the CFC-free HFA-beclomethasone metered- dose inhaler compared with CFC-beclomethasone. European Respiratory Journal 1998 12 6 1346 1353 2-s2.0-0032438394 10.1183/09031936.98.12061346 (Pubitemid 29011427)
10. Pritchard J. N., The influence of lung deposition on clinical response. Journal of Aerosol Medicine 2001 14 1 S19 S26 2-s2.0-0035117761 (Pubitemid 32172850)
11. Smyth H. D. C., Hickey A. J., Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers. AAPS PharmSciTech 2003 4 3 E38 2-s2.0-17944395204
12. Smyth H., Brace G., Barbour T., Gallion J., Grove J., Hickey A. J., Spray pattern analysis for metered dose inhalers: effect of actuator design. Pharmaceutical Research 2006 23 7 1591 1596 2-s2.0-33745620446 10.1007/s11095-006-0280-z (Pubitemid 43993822)
13. Smyth H., Hickey A. J., Brace G., Barbour T., Gallion J., Grove J., Spray pattern analysis for metered dose inhalers I: orifice size, particle size, and droplet motion correlations. Drug Development and Industrial Pharmacy 2006 32 9 1033 1041 2-s2.0-33749460787 10.1080/03639040600637598 (Pubitemid 44521821)
14. Feddah M. R., Brown K. F., Gipps E. M., Davies N. M., In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates. Journal of Pharmacy & Pharmaceutical Sciences 2000 3 3 318 324 2-s2.0-0034278559
15. Lewis D. A., Ganderton D., Meakin B. J., Brambilla G., Theory and practice with soultion systems. Respiratory Drug Delivery IX 2004 1 109 116
16. Gao Y., Li L. B., Zhai G., Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloids and Surfaces B 2008 64 2 194 199 2-s2.0-43849099717 10.1016/j.colsurfb.2008.01.021
17. Bromberg L., Polymeric micelles in oral chemotherapy. Journal of Controlled Release 2008 128 2 99 112 2-s2.0-43449084030 10.1016/j.jconrel.2008. 01.018
18. Kabanov A. V., Batrakova E. V., Alakhov V. Y., Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. Journal of Controlled Release 2002 82 2-3 189 212 2-s2.0-0037151313 10.1016/S0168-3659(02)00009-3 (Pubitemid 34880178)
19. Chokshi U., Selvam P., Porcar L., da Rocha S. R. P., Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles. International Journal of Pharmaceutics 2009 369 1-2 176 184 2-s2.0-60849136012 10.1016/j.ijpharm.2008.10.025
20. Dickinson P. A., Seville P. C., McHale H., Perkins N. C., Taylor G., An investigation of the solubility of various compounds in the hydrofluoroalkane propellants and possible model liquid propellants. Journal of Aerosol Medicine 2000 13 3 179 186 2-s2.0-0033744239
21. Traini D., Young P. M., Rogueda P., Price R., Investigation into the influence of polymeric stabilizing excipients on inter-particulate forces in pressurised metered dose inhalers. International Journal of Pharmaceutics 2006 320 1-2 58 63 2-s2.0-33746457772 10.1016/j.ijpharm.2006.04.016 (Pubitemid 44128717)
22. Ridder K. B., Davies-Cutting C. J., Kellaway I. W., Surfactant solubility and aggregate orientation in hydrofluoroalkanes. International Journal of Pharmaceutics 2005 295 1-2 57 65 2-s2.0-17644366769 10.1016/j.ijpharm.2005.01. 027 (Pubitemid 40558789)
23. Dalby R. N., Byron P. R., Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions. Pharmaceutical Research 1988 5 1 36 39 2-s2.0-0023859215
24. Stein S. W., Estimating the number of droplets and drug particles emitted from MDIs. AAPS PharmSciTech 2008 9 1 112 115 2-s2.0-44849090657 10.1208/s12249-007-9006-8
25. Stein S. W., Aiming for a moving target: challenges with impactor measurements of MDI aerosols. International Journal of Pharmaceutics 2008 355 1-2 53 61 2-s2.0-41349119146 10.1016/j.ijpharm.2007.11.047
26. Stein S. W., Myrdal P. B., A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions. Journal of Pharmaceutical Sciences 2004 93 8 2158 2175 2-s2.0-3843075402 10.1002/jps.20116 (Pubitemid 39045494)
27. Stephen W. S., Size distribution measurements of metered dose inhalers using Andersen Mark II cascade impactors. International Journal of Pharmaceutics 1999 186 1 43 52 2-s2.0-0032790249 10.1016/S0378-5173(99)00136-2 (Pubitemid 29397521)
28. Gabrio B. J., Stein S. W., Velasquez D. J., A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. International Journal of Pharmaceutics 1999 186 1 3 12 2-s2.0-0032764740 10.1016/S0378-5173(99)00133-7 (Pubitemid 29397518)
29. Stein S. W., Myrdal P. B., The relative influence of atomization and evaporation on metered dose inhaler drug delivery efficiency. Aerosol Science and Technology 2006 40 5 335 347 2-s2.0-34548567783 10.1080/02786820600612268
30. de Boer A. H., Gjaltema D., Hagedoorn P., Frijlink H. W., Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique. International Journal of Pharmaceutics 2002 249 1-2 219 231 2-s2.0-0037027831 10.1016/S0378-5173(02) 00526-4 (Pubitemid 35333448)
31. Naini V., Chaudhry S., Berry J., Sharpe S., Hart J., Sequeira J., Entry port selection for detecting particle size differences in metered dose inhaler formulations using cascade impaction. Drug Development and Industrial Pharmacy 2004 30 1 75 82 2-s2.0-1242343613 10.1081/DDC-120027514 (Pubitemid 38240478)